Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kay Lund

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 16, 2005
Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cellsShira Fruchtman, James G Simmons, Carmen Z Michaylira, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 20, 2003
Vitamin C intake and apoptosis in normal rectal epitheliumAlexandra E Connelly, Jessie Satia-Abouta, Christopher F Martin, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 1, 2006
Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivoCarmen Z Michaylira, James G Simmons, Nicole M Ramocki, et al.
Gastroenterology|August 10, 2004
Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferationMegan E Miller, Carmen Z Michaylira, James G Simmons, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 15, 2014
Deletion of intestinal epithelial insulin receptor attenuates high-fat diet-induced elevations in cholesterol and stem, enteroendocrine, and Paneth cell mRNAsSarah F Andres, M Agostina Santoro, Amanda T Mah, et al.
Surgery|July 29, 2008
Bacterial-dependent up-regulation of intestinal bile acid binding protein and transport is FXR-mediated following ileo-cecal resectionChristopher M Dekaney, Douglas C von Allmen, Aaron P Garrison, et al.
Gastroenterology|November 28, 2002
Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomasChristopher Martin, Alexandra Connelly, Temitope O Keku, et al.
Endocrinology|January 18, 2006
Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic miceCarmen Z Michaylira, Nicole M Ramocki, James G Simmons, et al.
Endocrinology|October 6, 2007
Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits Apcmin/+ tumors, and regulates Sox9Nicole M Ramocki, Heather R Wilkins, Scott T Magness, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 4, 2015
IGF1 stimulates crypt expansion via differential activation of 2 intestinal stem cell populationsLaurianne Van Landeghem, M Agostina Santoro, Amanda T Mah, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 16, 2005
Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cellsShira Fruchtman, James G Simmons, Carmen Z Michaylira, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 20, 2003
Vitamin C intake and apoptosis in normal rectal epitheliumAlexandra E Connelly, Jessie Satia-Abouta, Christopher F Martin, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 1, 2006
Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivoCarmen Z Michaylira, James G Simmons, Nicole M Ramocki, et al.
Gastroenterology|August 10, 2004
Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferationMegan E Miller, Carmen Z Michaylira, James G Simmons, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 15, 2014
Deletion of intestinal epithelial insulin receptor attenuates high-fat diet-induced elevations in cholesterol and stem, enteroendocrine, and Paneth cell mRNAsSarah F Andres, M Agostina Santoro, Amanda T Mah, et al.
Surgery|July 29, 2008
Bacterial-dependent up-regulation of intestinal bile acid binding protein and transport is FXR-mediated following ileo-cecal resectionChristopher M Dekaney, Douglas C von Allmen, Aaron P Garrison, et al.
Gastroenterology|November 28, 2002
Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomasChristopher Martin, Alexandra Connelly, Temitope O Keku, et al.
Endocrinology|January 18, 2006
Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic miceCarmen Z Michaylira, Nicole M Ramocki, James G Simmons, et al.
Endocrinology|October 6, 2007
Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits Apcmin/+ tumors, and regulates Sox9Nicole M Ramocki, Heather R Wilkins, Scott T Magness, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 4, 2015
IGF1 stimulates crypt expansion via differential activation of 2 intestinal stem cell populationsLaurianne Van Landeghem, M Agostina Santoro, Amanda T Mah, et al.
Pageof 6